Hiroaki Ida Selected Research

Melanoma (Melanoma, Malignant)

3/2022	Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy.
1/2017	Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
1/2016	An Autopsy Case of Anti-melanoma Differentiation-associated Gene-5 Antibody-positive Clinical Amyopathic Dermatomyositis Complicated by Rapidly Progressive Interstitial Lung Disease.
1/2015	Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroaki Ida Research Topics

Disease

31	Rheumatoid Arthritis 11/2023 - 02/2004
8	Inflammation (Inflammations) 10/2022 - 02/2004
7	Fever (Fevers) 10/2022 - 03/2009
7	Arthritis (Polyarthritis) 10/2022 - 03/2009
6	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023 - 08/2006
6	Dermatomyositis (Dermatopolymyositis) 11/2023 - 08/2006
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2014 - 01/2004
5	Edema (Dropsy) 10/2022 - 11/2007
4	Melanoma (Melanoma, Malignant) 03/2022 - 01/2015
4	Synovitis 09/2012 - 02/2004
3	Fibrosis (Cirrhosis) 11/2023 - 07/2022
2	Bronchiectasis 11/2023 - 11/2016
2	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023 - 01/2006
2	Idiopathic Interstitial Pneumonias 10/2022 - 04/2018
2	Thrombocytopenia (Thrombopenia) 10/2022 - 01/2020
2	Polymyositis 03/2022 - 10/2010
2	Vasculitis (Vasculitides) 01/2021 - 01/2006
2	Disease Progression 01/2020 - 01/2005
2	Hemoptysis 03/2015 - 07/2007
2	Macrophage Activation Syndrome 01/2015 - 04/2013
2	Infections 07/2011 - 01/2007
2	Disease Susceptibility (Diathesis) 06/2011 - 08/2010
2	Osteoarthritis 03/2011 - 02/2004
2	Hemorrhage 06/2009 - 07/2007
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2009 - 01/2008
2	Liver Diseases (Liver Disease) 01/2007 - 01/2004
2	Polyarteritis Nodosa (Periarteritis Nodosa) 04/2006 - 01/2006
2	Autoimmune Diseases (Autoimmune Disease) 01/2005 - 12/2003
1	Respiratory Insufficiency (Respiratory Failure) 11/2023
1	Idiopathic Pulmonary Fibrosis 11/2023
1	VEXAS syndrome 08/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Neoplasms (Cancer) 10/2022
1	Headache (Headaches) 10/2022
1	Multi-centric Castleman's Disease 10/2022
1	Sialadenitis 07/2022
1	Myalgia 09/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Amyloidosis 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 06/2018
1	Meningitis 01/2017

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 10/2022 - 12/2003
9	Prednisolone (Predate)FDA LinkGeneric 11/2023 - 01/2004
9	AntibodiesIBA 10/2022 - 09/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2012 - 01/2002
6	EnzymesIBA 08/2023 - 12/2003
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2011
5	SteroidsIBA 04/2018 - 01/2006
5	Anti-Citrullinated Protein AntibodiesIBA 03/2013 - 01/2006
5	Immunoglobulin M (IgM)IBA 03/2013 - 01/2006
5	Tumor Necrosis Factor InhibitorsIBA 04/2012 - 02/2010
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2023 - 01/2017
4	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2006
4	Antirheumatic Agents (DMARD)IBA 01/2020 - 07/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2018 - 01/2010
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2014 - 08/2006
4	Tacrolimus (Prograf)FDA LinkGeneric 03/2014 - 07/2007
4	Rheumatoid FactorIBA 03/2013 - 01/2006
4	Etanercept (Enbrel)FDA Link 06/2011 - 01/2009
3	tocilizumab (atlizumab)FDA Link 10/2022 - 02/2010
3	Interleukin-6 (Interleukin 6)IBA 10/2022 - 11/2007
3	InterferonsIBA 10/2022 - 03/2011
3	C-Reactive ProteinIBA 01/2020 - 11/2007
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017 - 07/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 08/2006
3	GadoliniumIBA 09/2012 - 06/2009
3	Peptides (Polypeptides)IBA 06/2011 - 01/2009
3	cyclic citrullinated peptideIBA 06/2009 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 01/2006
2	Colchicine FDA LinkGeneric 09/2021 - 09/2014
2	Transfer RNA (tRNA)IBA 08/2021 - 12/2003
2	PyrinIBA 01/2020 - 01/2008
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 07/2007
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2016 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 05/2015
2	CytokinesIBA 01/2015 - 02/2004
2	Adalimumab (Humira)FDA Link 02/2012 - 09/2011
2	ImmunosorbentsIBA 03/2011 - 12/2003
2	Interleukin-18 (Interleukin 18)IBA 03/2011 - 02/2004
2	mizoribineIBA 12/2010 - 01/2010
2	Cartilage Oligomeric Matrix ProteinIBA 10/2010 - 06/2009
2	Infliximab (Remicade)FDA Link 02/2010 - 01/2006
2	HLA-DRB1*04:05 antigenIBA 11/2007 - 08/2006
2	GlucocorticoidsIBA 01/2006 - 01/2006
1	Calcineurin InhibitorsIBA 11/2023
1	PeriostinIBA 11/2023
1	Ustekinumab (CNTO 1275)FDA Link 01/2023
1	Antinuclear AntibodiesIBA 10/2022
1	Reticulin (Reticular Fiber)IBA 10/2022
1	AA amyloidosisIBA 10/2022
1	CollagenIBA 07/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2022
1	transcriptional intermediary factor 1IBA 03/2022
1	Rituximab (Mabthera)FDA Link 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020

Therapy/Procedure

14	Therapeutics 10/2022 - 01/2006
2	Traction 11/2023 - 11/2016
2	Plasmapheresis 01/2015 - 01/2006